183 related articles for article (PubMed ID: 27803163)
1. Identification of Anti-prion Compounds using a Novel Cellular Assay.
Imberdis T; Heeres JT; Yueh H; Fang C; Zhen J; Rich CB; Glicksman M; Beeler AB; Harris DA
J Biol Chem; 2016 Dec; 291(50):26164-26176. PubMed ID: 27803163
[TBL] [Abstract][Full Text] [Related]
2. Ethanolamine Is a New Anti-Prion Compound.
Uchiyama K; Hara H; Chida J; Pasiana AD; Imamura M; Mori T; Takatsuki H; Atarashi R; Sakaguchi S
Int J Mol Sci; 2021 Oct; 22(21):. PubMed ID: 34769172
[TBL] [Abstract][Full Text] [Related]
3. Charged bipolar suramin derivatives induce aggregation of the prion protein at the cell surface and inhibit PrPSc replication.
Nunziante M; Kehler C; Maas E; Kassack MU; Groschup M; Schätzl HM
J Cell Sci; 2005 Nov; 118(Pt 21):4959-73. PubMed ID: 16219680
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of PrP(Sc) formation in scrapie infected N2a cells by 5,7,8-trimethyl-3,4-dihydro-2H-1,4-benzoxazine derivatives.
Koukouli F; Paspaltsis I; Salta E; Xanthopoulos K; Koini EN; Calogeropoulou T; Sklaviadis T
Prion; 2012; 6(5):470-6. PubMed ID: 22918434
[TBL] [Abstract][Full Text] [Related]
5. Discovery of Novel Anti-prion Compounds Using In Silico and In Vitro Approaches.
Hyeon JW; Choi J; Kim SY; Govindaraj RG; Jam Hwang K; Lee YS; An SS; Lee MK; Joung JY; No KT; Lee J
Sci Rep; 2015 Oct; 5():14944. PubMed ID: 26449325
[TBL] [Abstract][Full Text] [Related]
6. Identification of Alprenolol Hydrochloride as an Anti-prion Compound Using Surface Plasmon Resonance Imaging.
Miyazaki Y; Ishikawa T; Kamatari YO; Nakagaki T; Takatsuki H; Ishibashi D; Kuwata K; Nishida N; Atarashi R
Mol Neurobiol; 2019 Jan; 56(1):367-377. PubMed ID: 29704200
[TBL] [Abstract][Full Text] [Related]
7. Overexpression of quality control proteins reduces prion conversion in prion-infected cells.
Thapa S; Abdulrahman B; Abdelaziz DH; Lu L; Ben Aissa M; Schatzl HM
J Biol Chem; 2018 Oct; 293(41):16069-16082. PubMed ID: 30154245
[TBL] [Abstract][Full Text] [Related]
8. Discovery of 2-aminothiazoles as potent antiprion compounds.
Ghaemmaghami S; May BC; Renslo AR; Prusiner SB
J Virol; 2010 Apr; 84(7):3408-12. PubMed ID: 20032192
[TBL] [Abstract][Full Text] [Related]
9. Identification of novel fluorescent probes preventing PrP
Zaccagnini L; Brogi S; Brindisi M; Gemma S; Chemi G; Legname G; Campiani G; Butini S
Eur J Med Chem; 2017 Feb; 127():859-873. PubMed ID: 27842893
[TBL] [Abstract][Full Text] [Related]
10. Discovery of small molecules binding to the normal conformation of prion by combining virtual screening and multiple biological activity evaluation methods.
Li L; Wei W; Jia WJ; Zhu Y; Zhang Y; Chen JH; Tian J; Liu H; He YX; Yao X
J Comput Aided Mol Des; 2017 Dec; 31(12):1053-1062. PubMed ID: 29159521
[TBL] [Abstract][Full Text] [Related]
11. Utility of RNAi-mediated prnp gene silencing in neuroblastoma cells permanently infected by prions: potentials and limitations.
Kim Y; Han B; Titlow W; Mays CE; Kwon M; Ryou C
Antiviral Res; 2009 Nov; 84(2):185-93. PubMed ID: 19748523
[TBL] [Abstract][Full Text] [Related]
12. The charge structure of helix 1 in the prion protein regulates conversion to pathogenic PrPSc.
Norstrom EM; Mastrianni JA
J Virol; 2006 Sep; 80(17):8521-9. PubMed ID: 16912302
[TBL] [Abstract][Full Text] [Related]
13. Piperazine derivatives inhibit PrP/PrP(res) propagation in vitro and in vivo.
Leidel F; Eiden M; Geissen M; Hirschberger T; Tavan P; Giese A; Kretzschmar HA; Schätzl H; Groschup MH
Biochem Biophys Res Commun; 2014 Feb; 445(1):23-9. PubMed ID: 24502948
[TBL] [Abstract][Full Text] [Related]
14. A rapid method for detection of PrP by surface plasmon resonance (SPR).
Jiayu W; Xiong W; Jiping L; Wensen L; Ming X; Linna L; Jing X; Haiying W; Hongwei G
Arch Virol; 2009; 154(12):1901-8. PubMed ID: 19862471
[TBL] [Abstract][Full Text] [Related]
15. Effect of poly-L-arginine in inhibiting scrapie prion protein of cultured cells.
Waqas M; Lee HM; Kim J; Telling G; Kim JK; Kim DH; Ryou C
Mol Cell Biochem; 2017 Apr; 428(1-2):57-66. PubMed ID: 28063003
[TBL] [Abstract][Full Text] [Related]
16. Establishment of a simple cell-based ELISA for the direct detection of abnormal isoform of prion protein from prion-infected cells without cell lysis and proteinase K treatment.
Shan Z; Yamasaki T; Suzuki A; Hasebe R; Horiuchi M
Prion; 2016 Jul; 10(4):305-18. PubMed ID: 27565564
[TBL] [Abstract][Full Text] [Related]
17. Scrapie prion protein accumulation by scrapie-infected neuroblastoma cells abrogated by exposure to a prion protein antibody.
Enari M; Flechsig E; Weissmann C
Proc Natl Acad Sci U S A; 2001 Jul; 98(16):9295-9. PubMed ID: 11470893
[TBL] [Abstract][Full Text] [Related]
18. Generation, optimization and characterization of novel anti-prion compounds.
Altieri A; Spiridonov EA; Sivtzev SI; Ishibashi D; Biggi S; Nishida N; Biasini E; Kurkin AV
Bioorg Med Chem; 2020 Nov; 28(21):115717. PubMed ID: 33065443
[TBL] [Abstract][Full Text] [Related]
19. Anti-prion Protein Antibody 6D11 Restores Cellular Proteostasis of Prion Protein Through Disrupting Recycling Propagation of PrP
Pankiewicz JE; Sanchez S; Kirshenbaum K; Kascsak RB; Kascsak RJ; Sadowski MJ
Mol Neurobiol; 2019 Mar; 56(3):2073-2091. PubMed ID: 29987703
[TBL] [Abstract][Full Text] [Related]
20. Soluble dimeric prion protein binds PrP(Sc) in vivo and antagonizes prion disease.
Meier P; Genoud N; Prinz M; Maissen M; Rülicke T; Zurbriggen A; Raeber AJ; Aguzzi A
Cell; 2003 Apr; 113(1):49-60. PubMed ID: 12679034
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
